Resultados de la búsqueda 541-550 of 11590 for Hepatitis B infection

  1. Cirugía - Médicos - Mayo Clinic

    ... Hepatitis C, Hepatitis B, Hígado g...raso no alcohólico, Cirrosis biliar primaria, Cáncer del conducto biliar, Colangitis esclerosante primaria, Enfermedad ...

  2. Cáncer de hígado - Médicos y departamentos - Mayo Clinic

    gastroenterólogo; Hepatólogo del trasplante. Phoenix, AZ. Áreas de desarrollo: Hepatitis C, Hepatitis B, Hipertensión portal, carcinoma hepatocelular. Feedback.

  3. Hematología - Ensayos clínicos - Mayo Clinic

    CD19-Directed CAR-T Cell Therapy For The Treatment Of Relapsed/​Refractory B Cell Malignancies ... T cells fight infections and, in some cases, can also kill ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  5. Transplant Center de Mayo Clinic - Médicos

    ica alcohólica, Hepatitis C, Hepatitis B, Hígado graso no alcohólico, Cirrosis biliar primaria, tumor en el hígado, Cáncer del conducto biliar, Colangitis ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    CD19-Directed CAR-T Cell Therapy For The Treatment Of Relapsed/​Refractory B Cell Malignancies ... T cells fight infections and, in some cases, can also kill ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...